Cargando…
Empagliflozin-associated postoperative mixed metabolic acidosis. Case report and review of pathogenesis
BACKGROUND: Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors is a rare, relatively new and potentially fatal clinical entity, characterized by metabolic acidosis with normal or only moderately elevated glycemia. The mechanisms are not fully understood but involve increased ketogenes...
Autores principales: | Sitina, Michal, Lukes, Marek, Sramek, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103020/ https://www.ncbi.nlm.nih.gov/pubmed/37060078 http://dx.doi.org/10.1186/s12902-023-01339-w |
Ejemplares similares
-
Correction: Empagliflozin-associated postoperative mixed metabolic acidosis. Case report and review of pathogenesis
por: Sitina, Michal, et al.
Publicado: (2023) -
Prognostic significance of early acute kidney injury in COVID-19 patients requiring mechanical ventilation: a single-center retrospective analysis
por: Sitina, Michal, et al.
Publicado: (2023) -
Sodium chloride: Metabolic acidosis: case report
Publicado: (2021) -
Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review
por: Kamar, Fareed B., et al.
Publicado: (2015) -
Type B Lactic Acidosis Secondary to Malignancy: Case Report, Review of Published Cases, Insights into Pathogenesis, and Prospects for Therapy
por: Ruiz, Juan P., et al.
Publicado: (2011)